Disclosure Of Intangible Assets [Text Block]

Cinclus Pharma Holding AB - Filing #5879291

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of intangible assets [text block]
Research and development expense
136 657 SEK
166 678 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.